These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2982345)

  • 21. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides.
    Ferguson M; Reed SE; Minor PD
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2527-31. PubMed ID: 2431104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A monoclonal antibody that neutralizes poliovirus by cross-linking virions.
    Thomas AA; Brioen P; Boeyé A
    J Virol; 1985 Apr; 54(1):7-13. PubMed ID: 2983121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postabsorption neutralization of poliovirus.
    Vrijsen R; Mosser A; Boeyé A
    J Virol; 1993 Jun; 67(6):3126-33. PubMed ID: 8388493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralization of poliovirus by antibody-mediated polymerization.
    Brioen P; Dekegel D; Boeyé A
    Virology; 1983 Jun; 127(2):463-8. PubMed ID: 6306919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein.
    Emini EA; Dorner AJ; Dorner LF; Jameson BA; Wimmer E
    Virology; 1983 Jan; 124(1):144-51. PubMed ID: 6186073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of neutralization of animal viruses.
    Dimmock NJ
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1015-22. PubMed ID: 6202836
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody.
    Uytdehaag FG; Osterhaus AD
    J Immunol; 1985 Feb; 134(2):1225-9. PubMed ID: 2981264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
    Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
    J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
    Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
    Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes.
    Puligedda RD; Kouiavskaia D; Al-Saleem FH; Kattala CD; Nabi U; Yaqoob H; Bhagavathula VS; Sharma R; Chumakov K; Dessain SK
    Vaccine; 2017 Oct; 35(41):5455-5462. PubMed ID: 28343771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
    Thibodeau L; Lacroix M; Lecomte J; Fauvel M
    Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4.
    Minor PD; Ferguson M; Katrak K; Wood D; John A; Howlett J; Dunn G; Burke K; Almond JW
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2475-81. PubMed ID: 1717641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intertypic cross-neutralization of polioviruses by human monoclonal antibodies.
    Uhlig H; Dernick R
    Virology; 1988 Mar; 163(1):214-7. PubMed ID: 2831657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus.
    Schofield DJ; Stephenson JR; Dimmock NJ
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2441-6. PubMed ID: 9349462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?
    Yoden S; Kida H; Yanagawa R
    Arch Virol; 1985; 85(3-4):209-16. PubMed ID: 2411245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction.
    Mandel B
    Virology; 1976 Feb; 69(2):500-10. PubMed ID: 176784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.